Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)
Literature
Read More
PAK4 as a potential marker for poor response to immunotherapy in melanoma patients
Literature
Read More
NeoGenomics and Liquid Biopsy Subsidiary Inivata and Collaborators to Present New Data at ESMO Congress 2022
Press Release
Read More